ArticleJournal of hematology & oncology2013

Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma.

Chan-Juan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.